Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

FELODIPINE

FELODIPINE

Standard Dose
5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview FELODIPINE is listed in Drugs@FDA under application 210847 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FELODIPINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 5MG Sponsor YILING Submission history Latest submission status date: 2018-10-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview FELODIPINE is listed in Drugs@FDA under application 210847 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FELODIPINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 5MG Sponsor YILING Submission history Latest submission status date: 2018-10-26 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.